PET-MRI Assessment of Early Tumor Response to Predict Outcomes of HPV-Positive Oropharynx Cancer Patients

Conditions:   Squamous Cell Carcinoma;   Oropharynx Cancer
Interventions:   Radiation: Intensity modulated radiotherapy (IMRT);   Drug: Chemotherapy;   Diagnostic Test: PET-MRI
Sponsors:   University of Wisconsin, Madison;   National Cancer Institute (NCI);   National Institute of Dental and Craniofacial Research (NIDCR)
Not yet recruiting

http://ift.tt/2ipqaMQ